Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹14,284 Cr
Revenue (TTM)
₹1,030 Cr
Net Profit (TTM)
₹305 Cr
ROE
21.5 %
ROCE
28.9 %
P/E Ratio
46.8
P/B Ratio
12.6
Industry P/E
51.38
EV/EBITDA
33.4
Div. Yield
0 %
Debt to Equity
0
Book Value
₹65.3
EPS
₹17.6
Face value
2
Shares outstanding
173,465,425
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Blue Jet Health
| 45.9 | 11.8 | 13.9 | 126.2 | -- | -- | -- |
|
BSE Healthcare
| -6.0 | 2.8 | 6.4 | 20.7 | 23.9 | 23.1 | 9.9 |
|
BSE Mid Cap
| -3.0 | 8.5 | 13.3 | 7.4 | 27.3 | 31.4 | 15.6 |
|
Company
|
2024
|
|---|---|
|
Blue Jet Health
| 53.4 |
|
BSE Mid Cap
| 25.8 |
|
BSE Healthcare
| 43.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Blue Jet Health
|
823.7 | 14,284.0 | 1,030.0 | 305.2 | 34.9 | 29.7 | 46.8 | 12.6 |
| 455.0 | 4,152.8 | 2,387.0 | 168.1 | 9.7 | 12.7 | 24.7 | 3.0 | |
| 1,142.6 | 14,031.2 | 2,386.9 | 485.6 | 26.1 | 18.1 | 28.9 | 5.0 | |
| 1,498.9 | 15,742.1 | 1,089.2 | 328.2 | 36.4 | 20.9 | 48.2 | 9.5 | |
| 6,279.5 | 1,66,750.1 | 9,360.0 | 2,191.0 | 27.4 | 15.3 | 76.1 | 11.7 | |
| 1,064.4 | 20,157.2 | 6,658.3 | 527.6 | -- | 19.5 | 40.5 | 4.7 | |
| 11,056.0 | 14,181.1 | 1,476.8 | 260.1 | 17.5 | 13.7 | 54.5 | 9.3 | |
| 767.1 | 3,893.5 | 901.6 | 110.1 | 9.3 | 9.2 | 35.3 | 3.1 | |
| 188.7 | 4,118.3 | 6.7 | -160.8 | -2,578.1 | -106.2 | -- | 37.4 | |
| 593.2 | 4,171.9 | 1,873.4 | -31.7 | 5.2 | 4.1 | -- | 1.7 |
4 min read•By Nipun Arora
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for applications in pharmaceutical and healthcare products. It provides integrated contrast media... intermediates, saccharin and related salts, and niche pharmaceutical intermediates and APIs, as well as CDMO/CMO and development services. Blue Jet Healthcare Limited has operations in India, Norway, the United States, Sweden, Italy, Spain, and internationally. The company was incorporated in 1968 and is headquartered in Thane, India. Read more
Incorporated
1968
Chairman
Akshay Bansarilal Arora
Managing Director
Shiven Akshay Arora
Headquarters
Thane, Maharashtra
Website
Looking for more details about Blue Jet Healthcare Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Blue Jet Healthcare Ltd stood at ₹ 1,418 Cr as on 31-Mar-25
The share price of Blue Jet Healthcare Ltd is ₹823.70 (NSE) and ₹823.45 (BSE) as of 16-May-2025 15:58 IST. Blue Jet Healthcare Ltd has given a return of 126.2% in the last 1 years.
Blue Jet Healthcare Ltd has a market capitalisation of ₹ 14,284 Cr as on 16-May-2025. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Blue Jet Healthcare Ltd is 12.61 times as on 16-May-2025, a 304% premium to its peers’ median range of 3.12 times.
The P/E ratio of Blue Jet Healthcare Ltd is 46.80 times as on 16-May-2025, a 9% discount to its peers’ median range of 51.38 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Blue Jet Healthcare Ltd and enter the required number of quantities and click on buy to purchase the shares of Blue Jet Healthcare Ltd.
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for applications in pharmaceutical and healthcare products. It provides integrated contrast media intermediates, saccharin and related salts, and niche pharmaceutical intermediates and APIs, as well as CDMO/CMO and development services. Blue Jet Healthcare Limited has operations in India, Norway, the United States, Sweden, Italy, Spain, and internationally. The company was incorporated in 1968 and is headquartered in Thane, India.
The prominent promoters of Blue Jet Healthcare Ltd are
| Name of promoters | Holding percentage |
|---|---|
|
Akshay Bansarilal Arora |
68.99%
|
|
Shiven Akshay Arora |
10.96%
|
|
Archana Akshay Arora |
6.05%
|
The chairman of the company is Akshay Bansarilal Arora, and the managing director is Shiven Akshay Arora.
There is no promoter pledging in Blue Jet Healthcare Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
20,157
|
|
|
15,742
|
|
|
14,181
|
|
|
14,031
|
|
|
1,66,750
|
|
|
4,172
|
|
|
4,153
|
|
|
4,118
|
|
|
3,893
|
| Blue Jet Healthcare Ltd | Ratios |
|---|---|
|
Return on equity(%)
|
29.67
|
|
Operating margin(%)
|
34.95
|
|
Net Margin(%)
|
28.36
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Blue Jet Healthcare Ltd was ₹305 Cr.
₹-15.00
(
